What is the CVR number of Skejby Reprogenetics ApS?

Skejby Reprogenetics ApS is registered with CVR / Virk under CVR 37254975.

What is the revenue of Skejby Reprogenetics ApS?

Skejby Reprogenetics ApS reported revenue of DKK -30K in 2017.

Who is the CEO of Skejby Reprogenetics ApS?

Jørn Aagaard is Management of Skejby Reprogenetics ApS, in role since 2015.

Who is the chairman of Skejby Reprogenetics ApS?

Sue Channon chairs the board of Skejby Reprogenetics ApS, in role since 2016.

Where is Skejby Reprogenetics ApS headquartered?

Skejby Reprogenetics ApS's registered address is Hedeager 35.

Skejby Reprogenetics ApS

APSDissolved

CVR 37254975Hedeager 35Economic activity was not specified by tax authority · NACE 0000Est. 2015— employees

Full Risika report

Revenue 2017

DKK -30K

+74% vs 2016

EBITDA margin

100.0%

-74% vs 2016

Equity ratio

45.0%

Financial strength

Net profit 2017

DKK -23K

-74% vs 2016

EBITDA — year on yearDKK millions

Key figuresAnnual report 2017

Revenue	DKK -30K	+74%
EBITDA	DKK -30K	-74%
Net profit	DKK -23K	-74%
Total assets	DKK 30K	-44%
Equity	DKK 13K	-63%
Employees	—	—

Item	2016	2017
Revenue	-17	-30
Staff expenses	-0	-0
EBITDA	-17	-30
Depreciation & amort.	-0	-0
EBIT	-17	-30
Net financials	0	0
Profit before tax	-17	-30
Tax	-4	-7
Net profit	-13	-23

Item	2016	2017
Total assets	53	30
Equity	37	13
Long-term debt	0	0
Short-term debt	16	16
Total debt	16	16

Name	Role	Member since	Age	Other directorships
JA Jørn Aagaard Management	Management	2015	—	—

Name	Role	Member since	Age	Other directorships
SC Sue Channon	Chairman	2016	—	—
GP Glenn Patrick Powers	Board of Directors	2016	—	—
CC Conor Cuthill	Board of Directors	2016	—	—

Shareholder	Type	Ownership	Votes	Since
NY HEDESKOV HOLDING ApS	Company	100.0%	100.0%	2015
Virtus Health Europe Limited	Individual	100.0%	100.0%	2016

Person	Role here	Other companies
Jørn Aagaard	Management	0 companies
Sue Channon	Chairman	0 companies
Glenn Patrick Powers	Board of Directors	0 companies
Conor Cuthill	Board of Directors	0 companies

Skejby Reprogenetics ApS

APSDissolved

CVR 37254975Hedeager 35Economic activity was not specified by tax authority · NACE 0000Est. 2015— employees

Full Risika report

Revenue 2017

DKK -30K

+74% vs 2016

EBITDA margin

100.0%

-74% vs 2016

Equity ratio

45.0%

Financial strength

Net profit 2017

DKK -23K

-74% vs 2016

EBITDA — year on yearDKK millions

Key figuresAnnual report 2017

Revenue	DKK -30K	+74%
EBITDA	DKK -30K	-74%
Net profit	DKK -23K	-74%
Total assets	DKK 30K	-44%
Equity	DKK 13K	-63%
Employees	—	—